A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults
With rising obesity, it is becoming increasingly difficult to distinguish between type 1 diabetes (T1D) and type 2 diabetes (T2D) in young adults. There has been substantial recent progress in identifying the contribution of common genetic variants to T1D and T2D. We aimed to determine whether a score generated from common genetic variants could be used to discriminate between T1D and T2D and also to predict severe insulin deficiency in young adults with diabetes. We developed genetic risk scores (GRSs) from published T1D- and T2D-associated variants. We first tested whether the scores could distinguish clinically defined T1D and T2D from the Wellcome Trust Case Control Consortium (WTCCC) (n = 3,887). We then assessed whether the T1D GRS correctly classified young adults (diagnosed at 20-40 years of age, the age-group with the most diagnostic difficulty in clinical practice; n = 223) who progressed to severe insulin deficiency <3 years from diagnosis. In the WTCCC, the T1D GRS, based on 30 T1D-associated risk variants, was highly discriminative of T1D and T2D (area under the curve [AUC] 0.88 [95% CI 0.87-0.89]; P < 0.0001), and the T2D GRS added little discrimination (AUC 0.89). A T1D GRS >0.280 (>50th centile in those with T1D) is indicative of T1D (50% sensitivity, 95% specificity). A low T1D GRS (<0.234, <5th centile T1D) is indicative of T2D (53% sensitivity, 95% specificity). Most discriminative ability was obtained from just nine single nucleotide polymorphisms (AUC 0.87). In young adults with diabetes, T1D GRS alone predicted progression to insulin deficiency (AUC 0.87 [95% CI 0.82-0.92]; P < 0.0001). T1D GRS, autoantibody status, and clinical features were independent and additive predictors of severe insulin deficiency (combined AUC 0.96 [95% CI 0.94-0.99]; P < 0.0001). A T1D GRS can accurately identify young adults with diabetes who will require insulin treatment. This will be an important addition to correctly classifying individuals with diabetes when clinical features and autoimmune markers are equivocal..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:39 |
|---|---|
| Enthalten in: |
Diabetes care - 39(2016), 3, Seite 337 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Oram, Richard A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Care and treatment |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1972788299 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1972788299 | ||
| 003 | DE-627 | ||
| 005 | 20230714183601.0 | ||
| 007 | tu | ||
| 008 | 160427s2016 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a PQ20160430 |
| 035 | |a (DE-627)OLC1972788299 | ||
| 035 | |a (DE-599)GBVOLC1972788299 | ||
| 035 | |a (PRQ)g1406-1e66b8214436a01975ee0528eeaaad8dc72500fb157cffc263b4e1f82cc229830 | ||
| 035 | |a (KEY)0056447820160000039000300337type1diabetesgeneticriskscorecanaiddiscriminationb | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 100 | 1 | |a Oram, Richard A |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a With rising obesity, it is becoming increasingly difficult to distinguish between type 1 diabetes (T1D) and type 2 diabetes (T2D) in young adults. There has been substantial recent progress in identifying the contribution of common genetic variants to T1D and T2D. We aimed to determine whether a score generated from common genetic variants could be used to discriminate between T1D and T2D and also to predict severe insulin deficiency in young adults with diabetes. We developed genetic risk scores (GRSs) from published T1D- and T2D-associated variants. We first tested whether the scores could distinguish clinically defined T1D and T2D from the Wellcome Trust Case Control Consortium (WTCCC) (n = 3,887). We then assessed whether the T1D GRS correctly classified young adults (diagnosed at 20-40 years of age, the age-group with the most diagnostic difficulty in clinical practice; n = 223) who progressed to severe insulin deficiency <3 years from diagnosis. In the WTCCC, the T1D GRS, based on 30 T1D-associated risk variants, was highly discriminative of T1D and T2D (area under the curve [AUC] 0.88 [95% CI 0.87-0.89]; P < 0.0001), and the T2D GRS added little discrimination (AUC 0.89). A T1D GRS >0.280 (>50th centile in those with T1D) is indicative of T1D (50% sensitivity, 95% specificity). A low T1D GRS (<0.234, <5th centile T1D) is indicative of T2D (53% sensitivity, 95% specificity). Most discriminative ability was obtained from just nine single nucleotide polymorphisms (AUC 0.87). In young adults with diabetes, T1D GRS alone predicted progression to insulin deficiency (AUC 0.87 [95% CI 0.82-0.92]; P < 0.0001). T1D GRS, autoantibody status, and clinical features were independent and additive predictors of severe insulin deficiency (combined AUC 0.96 [95% CI 0.94-0.99]; P < 0.0001). A T1D GRS can accurately identify young adults with diabetes who will require insulin treatment. This will be an important addition to correctly classifying individuals with diabetes when clinical features and autoimmune markers are equivocal. | ||
| 540 | |a Nutzungsrecht: © 2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. | ||
| 650 | 4 | |a Obesity | |
| 650 | 4 | |a Health aspects | |
| 650 | 4 | |a Risk factors | |
| 650 | 4 | |a Care and treatment | |
| 650 | 4 | |a Type 2 diabetes | |
| 650 | 4 | |a Dosage and administration | |
| 650 | 4 | |a Teenagers | |
| 650 | 4 | |a Youth | |
| 650 | 4 | |a Insulin | |
| 650 | 4 | |a Risk assessment | |
| 650 | 4 | |a Young adults | |
| 650 | 4 | |a Diabetes | |
| 650 | 4 | |a Polymorphism | |
| 700 | 1 | |a Patel, Kashyap |4 oth | |
| 700 | 1 | |a Hill, Anita |4 oth | |
| 700 | 1 | |a Shields, Beverley |4 oth | |
| 700 | 1 | |a McDonald, Timothy J |4 oth | |
| 700 | 1 | |a Jones, Angus |4 oth | |
| 700 | 1 | |a Hattersley, Andrew T |4 oth | |
| 700 | 1 | |a Weedon, Michael N |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Diabetes care |d Alexandria, Va. : Assoc., 1978 |g 39(2016), 3, Seite 337 |w (DE-627)167285491 |w (DE-600)441231-X |w (DE-576)015600602 |x 0149-5992 |7 nnns |
| 773 | 1 | 8 | |g volume:39 |g year:2016 |g number:3 |g pages:337 |
| 856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/26577414 |
| 856 | 4 | 2 | |u http://search.proquest.com/docview/1774896698 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a GBV_ILN_2414 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4125 | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 39 |j 2016 |e 3 |h 337 | ||